Ayala Pharmaceuticals Inc (ADXS)

[bill_y]

shorts can cover during run-up on news or sell into it..i believe they have begun to cover with little success at these depressed pps levels. But adxs success is more about market share..EU is not a factor..current immuno treatments are way to expensive..there is a limit to what different countries can afford to pay to treat an individual citizen..but the US market is real target..adxs treatments can become SOC for hpv cervical subtypes..what's that worth..more than what it will cost to cover short interest no doubt..GOG is big factor and has already endorsed it with their own trials for hpv..the pps today is not the focus of long term investors ..just many of the posters..